Last edition
News about
GC Biopharma and Novel Pharma Sanfilippo Syndrome Treatment Receives FDA IND Approval
GC Biopharma and Novel Pharma has announced that its jointly developed MPS IIIA 'GC1130A' treatment has received FDA IND approval.
Cresilon Announces Distribution Agreement for VETIGEL in the UK and Europe
VETIGEL, a plant-based hemostatic gel designed to instantly stop and control bleeding, will be available online through Vi’s extensive range of surgical and orthopedic instruments.
Vector Laboratories and Absolute Biotech Announce Merger to Enhance Life Sciences Offerings
This strategic move aims to solidify Vector Laboratories' position as a comprehensive supplier of custom-engineered and catalog antibodies, sophisticated bioconjugation linkers, and expertise in bioconjugation.
Protein Dynamic Solutions Rolls Out ProteinMentor Platform Technology
Protein Dynamic Solutions has introduced its state-of-the-art ProteinMentor platform technology at the PEGS Boston Summit.
Jagsonpal Pharmaceuticals to Acquire India and Bhutan Business of Yash Pharma
Jagsonpal Pharmaceuticals Ltd. has signed a Business Transfer Agreement for the acquisition of India and Bhutan business of Yash Pharma for INR 92.47 Crores.
This new system features bipolar radiofrequency technology, and a new bipolar RF device called the Aveta Glo, representing a significant advancement in minimally invasive gynecologic procedures.
Watkins-Conti Products Gets FDA Approval for Yoni.Fit Bladder Support
Yoni.Fit® is intended for the temporary management of urine leakage caused by stress urinary incontinence (SUI) in women, 18 years and older.
Glenmark Secures ANDA Approval for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution
Glenmark Pharmaceuticals Ltd. has received final approval from the United States Food and Drug Administration (US FDA) for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution, 0.2 percent|0.5 percent.
Omega Laboratories Teams Up with Cannabix Technologies for Marijuana Breath Detection
Omega Laboratories has entered into a strategic partnership with Cannabix Technologies Inc., a pioneer in cannabis breathalyzer technology.
Siren Biotechnology and Catalent to Manufacture AAV Gene Therapies for Cancer
Siren Biotechnology has signed a strategic partnership with Catalent to support the development and manufacturing of Siren Biotechnology’s AAV immuno-gene therapies.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy